The research was led by members of the Ohio State faculty. It’s not that we need less generics, if anything we need MORE - but made in America or countries with high manufacturing standards: Israel, South Korea, France, and Germany come to mind. And affordably still at that!
I have received inequivalent generics at least 3 times. There are quantifiable problems. The worst was manufactured by Torrent labs in India, but that doesn’t mean all Indian generics are bad. It’s especially insidious with antidepressants, which may take weeks to ramp up to determine efficacy, but a bad generic, admittedly less common than a good one, can’t be distinguished from simply needing another AD.
A couple times it was probably due to insufficient active ingredient, but at least once I had a debilitating side effect for many months.
Country of origin should be on the label!